about
Two novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradationCytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells.The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.Characterization of a highly glycosylated form of the human cytomegalovirus HLA class I homologue gpUL18The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro.UL40-mediated NK evasion during productive infection with human cytomegalovirus.Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication.Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferonSequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture.Human cytomegalovirus UL40 signal peptide regulates cell surface expression of the NK cell ligands HLA-E and gpUL18Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression.Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation.Human Cytomegalovirus-Encoded Human Interleukin-10 (IL-10) Homolog Amplifies Its Immunomodulatory Potential by Upregulating Human IL-10 in MonocytesHuman cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responsesModulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus.Nuclear domain 10 components upregulated via interferon during human cytomegalovirus infection potently regulate viral infection.Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype.Adenovirus vector delivery stimulates natural killer cell recognition.Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death.Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus.Two novel spliced genes in human cytomegalovirus.Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus.Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.Abrogation of the interferon response promotes more efficient human cytomegalovirus replication.The most abundantly transcribed human cytomegalovirus gene (beta 2.7) is non-essential for growth in vitro.Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.Genetic content of wild-type human cytomegalovirus.Differential relocation and stability of PML-body components during productive human cytomegalovirus infection: detailed characterization by live-cell imaging.VZV ORF63 protects human neuronal and keratinocyte cell lines from apoptosis and changes its localization upon apoptosis induction.Varicella zoster virus productively infects human natural killer cells and manipulates phenotype.Restriction of human cytomegalovirus infection by galectin-9Interferon-Independent Upregulation of Interferon-Stimulated Genes during Human Cytomegalovirus Infection is Dependent on IRF3 ExpressionFunctional paralysis of human natural killer cells by alphaherpesviruses.Manipulation of the Innate Immune Response by Varicella Zoster VirusGal power: the diverse roles of galectins in regulating viral infectionsInterferon-Independent Innate Responses to CytomegalovirusGranzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity
P50
Q33553680-A7B5BCFC-D5F0-45A7-94EE-19F7D4009355Q33557172-FECEAC47-0CAB-47C3-97D0-6FFEA69883BAQ33744070-3BB2257E-37DB-42B8-9B15-938B038EA8D8Q33748410-FF51A470-5BDC-4AD4-B617-35BED2F46263Q33868941-07C3B62D-E75E-4C9F-A305-CC9A66569940Q34064598-02329882-05CE-4BEA-8A98-5A20343C99A8Q34090187-8010AF30-9764-47C3-90FB-C003992E7454Q34262198-651F7CDB-5FB2-4133-A7E6-127F218B5405Q34642568-4B1E70E7-D7E9-4837-8552-5303B22DFE6FQ35828380-14C2B48F-8231-4CAF-9EF1-FEA521C6891AQ35861220-660AE55C-E561-4D1D-9E0B-4303CDE04A48Q35947629-855FB433-F308-4E87-9807-87F2025F8958Q36432667-B59AFA3A-3048-444E-9DF4-434C0409D163Q36736415-90A3C177-38EF-4FBD-868C-0BB96AF91F5DQ37123220-C22D93C0-89AC-453E-9D94-057E5CFDEE96Q38234937-451A2F38-FD7E-4F6E-BB7F-CF6A9CFA93F9Q38696342-8988D28C-A66F-461E-A5E9-2E57AA247C02Q38761486-009385E7-A6CE-4AAD-A6A2-5DEF2722C083Q39706964-30E14425-40F4-416C-851A-88F5B07F1F50Q40125595-58A45139-7881-4584-A14E-EA07B9DF890EQ40481090-43A1D311-6FF4-4340-82B5-B83FDAF9EB10Q40655845-289DAFED-785D-4E9F-8CF8-93B4201A71D9Q40820097-CA53C0D8-0B3D-42FF-8EB2-402423C2BD73Q40900792-07F684AA-00DD-426B-A1BE-D4BCCDF1C6B5Q41665315-FE3299F0-9E39-426E-8E32-800204107A0BQ42605916-4523919C-451F-4DFA-89A4-5EE6B930BAA2Q43112464-0D2CC2DA-E96C-4C54-891B-382112E51532Q47709383-D90E9E55-7C77-47AD-AA59-363AECDEF769Q52601835-5DE1CB74-9A34-4D12-9FD6-8CB7DA9A9527Q52625007-7F4376A1-2A09-4FA9-AA3C-32EFB0D3EF1BQ55005159-C971945A-5F84-47C7-89A4-84194331FB6CQ59349678-6603D592-1F9B-43A9-B4CB-F0318FEFAFDEQ64106132-635ED86E-6BD0-4DB8-91CE-9011B71EDB41Q64986630-7ABC0707-1614-4603-92A8-01E64983C497Q89621258-F10773C0-58D4-445E-8E9B-FED91D8E2462Q91070520-A8E7020E-05EF-4399-89DD-8F1DF57B2E2BQ92538369-CE31B55B-1093-427B-84C8-50A95E56A96CQ92964769-59B3D09C-5613-42A6-92B8-167E84B6E1C6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brian P McSharry
@ast
Brian P McSharry
@en
Brian P McSharry
@es
Brian P McSharry
@nl
Brian P McSharry
@sl
type
label
Brian P McSharry
@ast
Brian P McSharry
@en
Brian P McSharry
@es
Brian P McSharry
@nl
Brian P McSharry
@sl
prefLabel
Brian P McSharry
@ast
Brian P McSharry
@en
Brian P McSharry
@es
Brian P McSharry
@nl
Brian P McSharry
@sl
P106
P21
P31
P496
0000-0003-0473-2789